Obesity in the United States is a medical crisis with many people attempting to lose weight with caloric restriction. Some patients choose minimally invasive weight loss solutions, such as intragastric balloon systems. These balloon systems were approved by the Federal Drug Administration (FDA) in 2015–2016 and have been considered safe, with minimal side effects. We report a patient with a two-day history of melena, abdominal pain, hypotension, and syncope which developed five months after placement of an intragastric balloon. Esophagogastroduodenoscopy with balloon removal revealed a small 8-mm gastric ulcer in the incisura. This gastric ulcer probably developed secondary to mechanical compression of the stomach mucosa by the gastric balloon which contained 900 mL of saline. The FDA is now investigating five deaths since 2016 associated with these second-generation balloons. Clinicians should be aware of these complications when evaluating patients with gastrointestinal complications, such as bleeding.
Citations
Citations to this article as recorded by
Gastric Perforation Secondary to a Hyperinflated Intragastric Balloon: A Case Report and Management Approach Solomon Raj Vasudayan, Guo Hou Loo, Guhan Muthkumaran, Nik Ritza Kosai Cureus.2025;[Epub] CrossRef
Prediction Factors of Early Postoperative Bleeding after Bariatric Surgery Mahdieh Golzarand, Karamollah Toolabi, Reza Parsaei Obesity Surgery.2022; 32(7): 1. CrossRef
Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation B. Betzel, M. I. Cooiman, E. O. Aarts, I. M. C. Janssen, P. J. Wahab, M. J. M. Groenen, J. P. H. Drenth, F. J. Berends Surgical Endoscopy.2020; 34(1): 209. CrossRef
Hidden dangers and updated labels on gastric balloons Sindhura Kolli, Andrew Ofosu, Harini Gurram, Simcha Weissman, Paul Khoi Dang‐Ho, Tej I. Mehta, Hailie Gill, Krishna C. Gurram Clinical Case Reports.2020; 8(11): 2116. CrossRef